NCT07237295

Brief Summary

In the United States, the burden of chronic kidney disease (CKD) rests disproportionately on rural communities. This study evaluates the implementation and effectiveness of CommunityRx-Kidney Health (CRx-K); this health information technology intervention integrates medical, social, and self-care resources to improve CKD management in rural eastern North Carolina. Through a partnership among local primary care centers, community organizations, and researchers, CRx-K will strengthen rural care networks, improve CKD management, and enhance the well-being of rural communities.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
634

participants targeted

Target at P75+ for not_applicable

Timeline
25mo left

Started Apr 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Apr 2026Jun 2028

First Submitted

Initial submission to the registry

November 14, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 19, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

April 13, 2026

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2028

Last Updated

April 30, 2026

Status Verified

April 1, 2026

Enrollment Period

2.1 years

First QC Date

November 14, 2025

Last Update Submit

April 29, 2026

Conditions

Keywords

Chronic disease managementCommunity resource referralHealth-related social needsHealthcare servicesKidney healthLongitudinal navigation supportRural healthSelf-efficacy

Outcome Measures

Primary Outcomes (1)

  • Acute healthcare utilization

    Acute healthcare utilization is measured as the sum of self-reported 911 calls, ambulance visits, emergency room visits, urgent care visits, and hospital admissions across the 12-month follow-up period.

    12 months

Secondary Outcomes (8)

  • Ambulatory healthcare utilization

    12 months

  • Self-efficacy for finding social and self-care resources

    6 months, 12 months

  • Attitudes about social and self-care resources

    6 months, 12 months

  • Knowledge of social and self-care resources

    6 months, 12 months

  • Use of social and self-care resources

    6 months, 12 months

  • +3 more secondary outcomes

Study Arms (2)

Intervention + usual care

EXPERIMENTAL

This arm will receive the intervention in addition to usual care.

Behavioral: CommunityRx-Kidney Health

Usual care only

NO INTERVENTION

This arm will not receive the intervention.

Interventions

CommunityRx-Kidney Health (CRx-K) is an evidence-based, low-intensity, health information technology-driven intervention designed to support chronic kidney disease management in rural eastern North Carolina. CRx-K integrates medical (e.g., blood pressure and glucose monitoring, eye and foot care), social (food, housing, transportation), and self-care (weight and stress management, exercise) resources. CRx-K comprises three components: brief education on integrated chronic kidney disease needs, a personalized community resource referral list (HealtheRx), and clinic navigator-led, longitudinal support (12 months) for chronic kidney disease patients.

Also known as: CRx-K
Intervention + usual care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of chronic kidney disease defined as ≥1 ICD-10 CKD codes (excluding end-stage kidney disease) or CKD biomarkers (estimated glomerular filtration rate ≤ 60 ml/min, albuminuria ≥30 mg/24h)
  • At least one clinic visit at Goshen Medical Center in 12 months before enrollment

You may not qualify if:

  • Limited life expectancy (e.g., advanced cancer, end-stage liver disease, hospice)
  • Active cancer treatment
  • Living in a skilled nursing facility
  • Dementia/other significant cognitive impairment/inability to participate in the informed consent process

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Goshen Medical Center

Beulaville, North Carolina, 28518, United States

RECRUITING

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Gaurav J Dave, MBBS, MPH, DrPH

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR
  • Abhijit V Kshirsagar, MD, MPH

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR
  • Stacy Tessler Lindau, MD, MA

    University of Chicago

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kristen D Witkemper, MPH

CONTACT

Erika M Redding, PhD, MSPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Investigators are masked to participant assignments. Unmasked research staff support enrollment, randomization, and data collection; unmasked navigators deliver the intervention to participants randomized to the active arm. Participant masking is not possible, as participants in the active condition will receive the three CRx-K components described during the consent process.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: The research team will use REDCap's randomization module to individually randomize eligible participants to the CRx-K or usual care in a 1:1 ratio stratified by the number of providers (1, 2, or 3+) at each clinic site.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2025

First Posted

November 19, 2025

Study Start

April 13, 2026

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

June 1, 2028

Last Updated

April 30, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

De-identified individual data that supports the results will be shared provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with The University of North Carolina at Chapel Hill.

Shared Documents
STUDY PROTOCOL, ICF, ANALYTIC CODE
Time Frame
Beginning 9 and continuing for 36 months following publication
Access Criteria
Investigator has approved IRB, IEC, or REB and an executed data use/sharing agreement with The University of North Carolina at Chapel Hill

Locations